A new dataset from genomics company Helix aims to accelerate research into metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. The dataset, with information from more than 17,000 people, is part of Helix’s GenoSphere platform, which combines genetic and clinical data with the goal of improving scientific understanding of disease processes and […] The post New Helix dataset aims to accelerate liver disease research appeared first on Liver Disease ...
